Edited by two experts working at the pioneering pharmaceutical company and major global player in hormone-derived drugs, this handbook and reference systematically treats the drug development aspects of all human nuclear receptors, including recently characterized receptors such as PPAR, FXR and LXR. Authors from leading pharmaceutical companies around the world present examples and real-life data from their own work.

медицина / здравоохранение

фармакология

медицина

Nuclear Receptors as Drug Targets

Target Discovery and Validation

Neglected Tropical Diseases

Innovative Dosage Forms

Biomolecular Simulations in Structure-Based Drug Discovery

G Protein-Coupled Receptors as Drug Targets

Early Drug Development

Combinatorial Chemistry

Molecular Biology in Medicinal Chemistry